Discovery and naming
The journey began in 1912 when Alexis Alexeieff introduced a new genus for certain amoeboid forms. He named it Naegleria in honor of Nägler’s research on amoebae that undergo a biflagellate stage.
The specific pathogen responsible for PAM, Naegleria fowleri, was first identified in 1965 by Malcolm Fowler and Rodney F. Carter in Australia. They recorded the first human cases, highlighting the deadly nature of the infection.
In 1970, further research using mice helped isolate the pathogen, and it was officially named Naegleria fowleri in honor of Fowler, who identified the disease from human brain tissue samples.
Milestones
The term ‘primary amoebic meningoencephalitis’ was coined in 1966 by Butt to distinguish this infection from other types of meningoencephalitis.
Over the years, advancements in diagnostic tools have significantly improved our ability to detect and understand PAM. Amoeba cultures cerebrospinal fluid (CSF) and advances in molecular diagnostics, such as polymerase chain reaction (PCR), immunofluorescence, and enzyme-linked immunosorbent assay (ELISA) enhanced the speed and accuracy of diagnosis.
Imaging techniques like CT and MRI scans also play a crucial role in assessing the extent of brain damage.
Cultural impact and awareness
Naegleria fowleri has not been associated with any Nobel Prizes or landmark achievements in medicine, and little has been known about it for a long time.
However, this brain-eating amoeba was featured in an episode of the well-known American medical drama ‘House M.D.,’ which increased public awareness of brain infection and highlighted the dangerous nature of the infection.